Insights

Strategic Partnerships Caristo Diagnostics has active and growing collaborations with medical centers and cardiology networks such as Centralsydneycardiology and Biograph International, indicating a receptive market for expanding adoption of CaRi-Heart AI platform in clinical workflows and preventive cardiology programs.

Clinical Evidence Momentum Upcoming and recent presentations at SCCT and Oxford-led ORFAN registry evidence showcase provide compelling talking points for clinicians and procurement teams, suggesting opportunities to align sales pitches with hospital grant programs, value-based care initiatives, and payer discussions.

Executive Leadership New CEO and COO appointments signal a strategic scale-up and clear governance for commercialization, enabling targeted outreach to enterprise buyers, KOLs, and health systems seeking vetted AI-driven cardiovascular solutions.

Global Market Access Recognition as a 2026 World Economic Forum Technology Pioneer and multi-region collaborations position Caristo to approach international hospitals, academic centers, and preventive health clinics seeking innovative imaging analytics to enhance risk stratification and treatment planning.

Adoption Readiness Existing integration with widely used tech stack and digital tools (Vue.js, DocuSign, Google Tag Manager, cloud services) suggests a smoother onboarding path for health systems requiring secure contracts, data handling, and seamless EHR/CT workflow integration.

Similar companies to Caristo Diagnostics

Caristo Diagnostics Tech Stack

Caristo Diagnostics uses 8 technology products and services including Amazon Web Services, Docker, WordPress, and more. Explore Caristo Diagnostics's tech stack below.

Media & News

Caristo Diagnostics's Email Address Formats

Caristo Diagnostics uses at least 2 email formats:
Caristo Diagnostics Email FormatsExamplePercentage
First.Last@caristo.comJohn.Doe@caristo.com
98%
First@caristo.comJohn@caristo.com
2%

Frequently Asked Questions

What is Caristo Diagnostics's official website and social media links?

Minus sign iconPlus sign icon
Caristo Diagnostics's official website is caristo.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Caristo Diagnostics generate?

Minus sign iconPlus sign icon
As of August 2026, Caristo Diagnostics's annual revenue is estimated to be $1M - $10M.

What is Caristo Diagnostics's NAICS code?

Minus sign iconPlus sign icon
Caristo Diagnostics's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Caristo Diagnostics have currently?

Minus sign iconPlus sign icon
As of August 2026, Caristo Diagnostics has approximately 57 employees across 3 continents, including Europe, North America and South America. Key team members include Chief Development Officer: C. S., Head Of Quality And Regulatory Affairs: J. D. and Head Of Engineering: N. S. Explore Caristo Diagnostics's employee directory with LeadIQ.

What industry does Caristo Diagnostics belong to?

Minus sign iconPlus sign icon
Caristo Diagnostics operates in the Medical Equipment Manufacturing industry.

What technology does Caristo Diagnostics use?

Minus sign iconPlus sign icon
Caristo Diagnostics's tech stack includes Amazon Web Services, Docker, WordPress, GitLab CI, PostgreSQL, Zendesk, Shopify and DocuSign.

What is Caristo Diagnostics's email format?

Minus sign iconPlus sign icon
Caristo Diagnostics's email format typically follows the pattern of First.Last@caristo.com. Find more Caristo Diagnostics email formats with LeadIQ.

How much funding has Caristo Diagnostics raised to date?

Minus sign iconPlus sign icon
As of August 2026, Caristo Diagnostics has raised $30M in funding. The last funding round occurred on Sep 30, 2024 for $150K.

When was Caristo Diagnostics founded?

Minus sign iconPlus sign icon
Caristo Diagnostics was founded in 2017.
Caristo Diagnostics logo

Caristo Diagnostics

Medical Equipment ManufacturingEngland, United Kingdom51-200 Employees

Caristo Diagnostics develops AI-powered analysis of cardiac CT imaging to enhance cardiovascular risk assessment and guide treatment decisions. By extracting information not readily visible in routine scans, it aims to increase the accuracy of risk prediction and inform clinical decisions. The company is based in Oxford, England, and originated as a University of Oxford spinout, operating in the medical equipment manufacturing sector focused on cardiovascular diagnostics.

In April 2026, Caristo announced leadership appointments, naming Stephen M. Deitsch as Chief Executive Officer and appointing Frank as Chief Operating Officer.

Section iconCompany Overview

NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $30M

    Caristo Diagnostics has raised a total of $30M of funding over 4 rounds. Their latest funding round was raised on Sep 30, 2024 in the amount of $150K as a Venture Round.

  • $1M - $10M

    Caristo Diagnostics's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.